 Jennifer Matsuda
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 16 | 2018 | 449 | 1.880 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 14 | 2024 | 336 | 1.200 |
Why?
| | Antigens, CD1 | 9 | 2008 | 58 | 1.000 |
Why?
| | Natural Killer T-Cells | 7 | 2016 | 67 | 0.990 |
Why?
| | T-Lymphocyte Subsets | 6 | 2022 | 417 | 0.850 |
Why?
| | Antigens, CD1d | 15 | 2018 | 68 | 0.830 |
Why?
| | Cell Differentiation | 9 | 2018 | 1991 | 0.630 |
Why?
| | Galactosylceramides | 7 | 2010 | 25 | 0.550 |
Why?
| | Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.510 |
Why?
| | Cell Movement | 5 | 2020 | 967 | 0.500 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 5757 | 0.480 |
Why?
| | T-Lymphocytes | 8 | 2025 | 1996 | 0.480 |
Why?
| | Mice | 38 | 2025 | 17787 | 0.460 |
Why?
| | Th1 Cells | 2 | 2007 | 143 | 0.450 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1142 | 0.440 |
Why?
| | Antigen Presentation | 3 | 2018 | 218 | 0.400 |
Why?
| | Thymus Gland | 7 | 2024 | 312 | 0.380 |
Why?
| | Animals | 43 | 2025 | 36940 | 0.370 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.360 |
Why?
| | Immune Tolerance | 2 | 2025 | 363 | 0.340 |
Why?
| | Mice, Knockout | 13 | 2025 | 3015 | 0.330 |
Why?
| | Major Histocompatibility Complex | 2 | 2024 | 227 | 0.330 |
Why?
| | T-Box Domain Proteins | 3 | 2007 | 98 | 0.330 |
Why?
| | Models, Immunological | 2 | 2007 | 100 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2024 | 1091 | 0.320 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2016 | 367 | 0.320 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 4 | 2012 | 21 | 0.320 |
Why?
| | Interferon-gamma | 4 | 2015 | 789 | 0.300 |
Why?
| | Antigens | 5 | 2020 | 357 | 0.300 |
Why?
| | Lymphocyte Subsets | 2 | 2005 | 87 | 0.280 |
Why?
| | Mutation | 4 | 2020 | 3958 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 101 | 0.260 |
Why?
| | Inflammation | 5 | 2025 | 2837 | 0.250 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2025 | 26 | 0.240 |
Why?
| | Colon | 2 | 2025 | 282 | 0.240 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | HLA-DRB1 Chains | 1 | 2025 | 112 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.220 |
Why?
| | Autoantigens | 2 | 2011 | 430 | 0.210 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 12 | 0.210 |
Why?
| | NADPH Oxidases | 1 | 2024 | 113 | 0.210 |
Why?
| | Catecholamines | 1 | 2023 | 98 | 0.210 |
Why?
| | Phagocytes | 1 | 2024 | 101 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 160 | 0.200 |
Why?
| | Transcription Factors | 3 | 2005 | 1719 | 0.200 |
Why?
| | Glutamic Acid | 1 | 2025 | 246 | 0.200 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 37 | 0.200 |
Why?
| | Lung Injury | 1 | 2025 | 219 | 0.190 |
Why?
| | Interleukin-4 | 1 | 2003 | 216 | 0.190 |
Why?
| | Collagen | 1 | 2025 | 452 | 0.190 |
Why?
| | Dendritic Cells | 3 | 2020 | 483 | 0.190 |
Why?
| | Th2 Cells | 1 | 2003 | 176 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2025 | 287 | 0.190 |
Why?
| | Interleukin-15 | 1 | 2002 | 98 | 0.190 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2001 | 22 | 0.190 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 210 | 0.190 |
Why?
| | Histone Deacetylases | 1 | 2023 | 215 | 0.190 |
Why?
| | Adipocytes | 1 | 2023 | 222 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2025 | 886 | 0.180 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.170 |
Why?
| | Dermis | 1 | 2020 | 33 | 0.170 |
Why?
| | Signal Transduction | 4 | 2020 | 5079 | 0.170 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.170 |
Why?
| | Listeriosis | 1 | 2020 | 70 | 0.170 |
Why?
| | Intestinal Mucosa | 1 | 2025 | 623 | 0.160 |
Why?
| | Immunity | 1 | 2020 | 143 | 0.160 |
Why?
| | Listeria monocytogenes | 1 | 2020 | 126 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2607 | 0.160 |
Why?
| | Myeloid Cells | 1 | 2020 | 148 | 0.160 |
Why?
| | Respiratory Hypersensitivity | 2 | 2010 | 69 | 0.150 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 217 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2020 | 353 | 0.140 |
Why?
| | Mice, Transgenic | 6 | 2025 | 2167 | 0.140 |
Why?
| | Glycolipids | 1 | 2018 | 42 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2018 | 1272 | 0.140 |
Why?
| | Autoimmunity | 2 | 2020 | 908 | 0.140 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 480 | 0.140 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 30 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 496 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2022 | 847 | 0.130 |
Why?
| | Lung | 5 | 2025 | 4060 | 0.130 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2016 | 40 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2016 | 385 | 0.130 |
Why?
| | Apoptosis | 1 | 2025 | 2553 | 0.130 |
Why?
| | Lipids | 1 | 2001 | 672 | 0.130 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1167 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 842 | 0.120 |
Why?
| | Epithelial Cells | 3 | 2020 | 1096 | 0.120 |
Why?
| | Fibroblasts | 1 | 2020 | 996 | 0.120 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 225 | 0.110 |
Why?
| | Cellular Senescence | 1 | 2016 | 189 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4295 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 352 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2020 | 4193 | 0.110 |
Why?
| | Interleukins | 1 | 2015 | 250 | 0.100 |
Why?
| | Ovalbumin | 2 | 2010 | 183 | 0.100 |
Why?
| | Cytokines | 3 | 2025 | 2085 | 0.100 |
Why?
| | Tuberculosis | 1 | 2015 | 279 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 314 | 0.090 |
Why?
| | Alleles | 2 | 2025 | 891 | 0.090 |
Why?
| | Neutrophils | 1 | 2016 | 1238 | 0.090 |
Why?
| | Retroviridae | 2 | 2013 | 97 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2024 | 718 | 0.090 |
Why?
| | Phosphorylation | 3 | 2020 | 1759 | 0.080 |
Why?
| | Lung Diseases | 1 | 2016 | 767 | 0.080 |
Why?
| | Lymph Nodes | 3 | 2020 | 491 | 0.080 |
Why?
| | Macrophages | 1 | 2016 | 1547 | 0.080 |
Why?
| | Smoking | 1 | 2016 | 1627 | 0.070 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 10 | 0.070 |
Why?
| | Antigens, Ly | 2 | 2015 | 44 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2008 | 224 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2020 | 900 | 0.070 |
Why?
| | Receptors, CXCR3 | 1 | 2007 | 13 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 47 | 0.070 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 45 | 0.070 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2007 | 27 | 0.070 |
Why?
| | Allergens | 1 | 2010 | 409 | 0.070 |
Why?
| | Complementarity Determining Regions | 2 | 2007 | 51 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 202 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2900 | 0.060 |
Why?
| | Sphingomyelins | 1 | 2025 | 33 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3715 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 706 | 0.060 |
Why?
| | Sphingolipids | 1 | 2025 | 77 | 0.060 |
Why?
| | Humans | 12 | 2025 | 137585 | 0.060 |
Why?
| | Ceramides | 1 | 2025 | 118 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 976 | 0.060 |
Why?
| | Skin Transplantation | 1 | 2025 | 85 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2139 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 436 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 64 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 16 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 307 | 0.050 |
Why?
| | Receptors, Interleukin-12 | 1 | 2003 | 7 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 286 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| | Heterozygote | 1 | 2024 | 293 | 0.050 |
Why?
| | Immunity, Innate | 3 | 2016 | 828 | 0.050 |
Why?
| | Receptors, Interleukin | 1 | 2003 | 45 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 137 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 53 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2018 | 476 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 52 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 199 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2003 | 89 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1062 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2001 | 318 | 0.050 |
Why?
| | Lymphopenia | 1 | 2002 | 62 | 0.050 |
Why?
| | Cell Survival | 1 | 2005 | 1120 | 0.050 |
Why?
| | Interleukin-7 | 1 | 2002 | 61 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 183 | 0.050 |
Why?
| | Homeostasis | 2 | 2004 | 621 | 0.050 |
Why?
| | Clonal Anergy | 1 | 2022 | 52 | 0.050 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2001 | 27 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2022 | 119 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 202 | 0.050 |
Why?
| | Carbohydrate Sequence | 1 | 2001 | 27 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2001 | 24 | 0.040 |
Why?
| | Protein Conformation | 2 | 2018 | 934 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2001 | 28 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2020 | 14 | 0.040 |
Why?
| | Organ Specificity | 1 | 2001 | 305 | 0.040 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 32 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 601 | 0.040 |
Why?
| | Cell Division | 1 | 2002 | 794 | 0.040 |
Why?
| | Poly I-C | 1 | 2020 | 63 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2000 | 67 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 13 | 0.040 |
Why?
| | Antigens, Surface | 1 | 2000 | 154 | 0.040 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 127 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 199 | 0.040 |
Why?
| | Chemotaxis | 1 | 2020 | 131 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 161 | 0.040 |
Why?
| | Polymerization | 1 | 2020 | 124 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2002 | 302 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 324 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2000 | 87 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 171 | 0.040 |
Why?
| | CD4 Antigens | 1 | 2000 | 141 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 265 | 0.040 |
Why?
| | Epitopes | 1 | 2001 | 479 | 0.040 |
Why?
| | Exons | 1 | 2020 | 355 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 367 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2023 | 635 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 289 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 248 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 231 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1774 | 0.040 |
Why?
| | Actins | 1 | 2020 | 416 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2003 | 2833 | 0.040 |
Why?
| | Immunoglobulin Variable Region | 2 | 2012 | 80 | 0.040 |
Why?
| | Spleen | 1 | 2000 | 514 | 0.040 |
Why?
| | Cell Cycle | 1 | 2020 | 601 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2001 | 518 | 0.030 |
Why?
| | Female | 4 | 2020 | 73304 | 0.030 |
Why?
| | Bacteriolysis | 1 | 2016 | 9 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 497 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2181 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2016 | 18 | 0.030 |
Why?
| | Activin Receptors, Type II | 1 | 2016 | 12 | 0.030 |
Why?
| | Peroxidase | 1 | 2016 | 175 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 404 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 64 | 0.030 |
Why?
| | Bone Marrow Cells | 2 | 2010 | 316 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2013 | 1178 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 327 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 125 | 0.030 |
Why?
| | RNA Splice Sites | 1 | 2015 | 45 | 0.030 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 45 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1430 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2020 | 785 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3196 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2847 | 0.030 |
Why?
| | Transgenes | 1 | 2015 | 180 | 0.030 |
Why?
| | Proteins | 1 | 2000 | 1009 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1457 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 267 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2015 | 165 | 0.030 |
Why?
| | Thymocytes | 1 | 2013 | 36 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 87 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2475 | 0.020 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2020 | 657 | 0.020 |
Why?
| | Transfection | 1 | 2015 | 945 | 0.020 |
Why?
| | Immune System | 1 | 2013 | 177 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 391 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 985 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2224 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1242 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 163 | 0.020 |
Why?
| | Bronchial Hyperreactivity | 1 | 2010 | 111 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 219 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 239 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 143 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1250 | 0.020 |
Why?
| | Mutagenesis | 1 | 2009 | 179 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2009 | 534 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 664 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 257 | 0.020 |
Why?
| | Crystallography | 1 | 2007 | 28 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 14 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.020 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2007 | 21 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2007 | 43 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2010 | 513 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 298 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1570 | 0.020 |
Why?
| | Precipitin Tests | 1 | 2004 | 100 | 0.010 |
Why?
| | CpG Islands | 1 | 2004 | 157 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 156 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6828 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 112 | 0.010 |
Why?
| | Cloning, Organism | 1 | 2002 | 6 | 0.010 |
Why?
| | Immunoglobulin Joining Region | 1 | 2001 | 10 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 767 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1943 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2004 | 406 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 350 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 594 | 0.010 |
Why?
| | Aged | 1 | 2016 | 23961 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 33479 | 0.010 |
Why?
| | Male | 1 | 2020 | 67762 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1864 | 0.010 |
Why?
|
|
Matsuda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|